Bellinda Conte, Senior Vice President at Reimagine Care, shared on LinkedIn:
“This is a meaningful day.
For the past five years, I have had the privilege of helping build Reimagine Care not simply as a technology platform, but as a care model designed around what patients with cancer actually experience between visits.
We built the clinical operations behind that model with oncology-trained and experienced teams, workflows that integrate into cancer centers, and escalation pathways that patients and providers can rely on when something changes. We learned how to deliver this care consistently, safely and at scale and proved that virtual oncology care can be more than a promising pilot.
Now, as Reimagine Care joins Cureety, we have an opportunity to build on that foundation.
Cureety’s therapy-specific intelligence can help us better understand which risks matter for each patient, while our AI tech-enabled care model can help turn those insights into timely, personalized support.
That combination is powerful.
I am incredibly proud of what our team has built, grateful to the cancer centers that trusted us to care for their patients, and excited about what this next chapter can make possible.
We have come a long way and we are just getting started.”
To which Timothy Hembree, Vice President and Chief Quality Officer at Moffitt Cancer Center, added:
“This is an exciting announcement.
Moffitt Cancer Center is working with Reimagine Care and Cureety to build better comprehensive triage models based on disease and treatment specific algorithms.
‘Oncology is personalized medicine and the approach to support should be personalized as well.’
Congrats to Dan Nardi, Bellinda Conte and Misha Kaur.”
Other articles about AI in Oncology on OncoDaily.